PD-1 endocytosis unleashes the cytolytic potential of check-point blockade in tumor immunity

被引：0
|
作者：
Oroya, Andres [1 ,2 ]
Ben Saad, Elham [1 ]
Bachais, Meriem [1 ]
Rudd, Christopher [1 ]
机构：
[1] Univ Montreal, Hosp Maisonneuve Rosemont, Montreal, PQ, Canada
[2] Univ Montreal, Montreal, PQ, Canada
来源：
JOURNAL OF IMMUNOLOGY | 2024年 / 212卷 / 01期
关键词：
D O I：
10.4049/jimmunol.212.supp.0377.6071
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
    Mingxia Zhao
    Wenjie Guo
    Yuanyuan Wu
    Chenxi Yang
    Liang Zhong
    Guoliang Deng
    Yuyu Zhu
    Wen Liu
    Yanhong Gu
    Yin Lu
    Lingdong Kong
    Xiangbao Meng
    Qiang Xu
    Yang Sun
    ActaPharmaceuticaSinicaB, 2019, 9 (02) : 304 - 315
  • [22] Anti-tumor Efficacy with a Novel Peptide Inhibitor of the PD-1 Immune Check Point Pathway
    Ramachandra, M.
    Sasikumar, P. G.
    Satyam, L. K.
    Shrimali, R. K.
    Subbarao, K.
    Ramachandra, R.
    Vadlamani, S.
    Reddy, A.
    Sreenivas, A.
    Samiulla, D. S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 69 - 69
  • [23] Tumor growth inhibition and immune system activation following treatment with thorium-227 conjugates and PD-1 check-point inhibition in the MC-38 murine model
    Berg-Larsen, Axel
    Mobergslien, Anne
    Moen, Ingrid
    Petros, Gebregziabher
    Kristian, Alexander
    Gunvaldsen, Kristine Sponheim
    Cruciani, Veronique
    Wickstroem, Katrine
    Bjerke, Roger Malerbakken
    Karlsson, Jenny
    Cuthbertson, Alan
    FRONTIERS IN MEDICINE, 2022, 9
  • [24] Enhancing SIV-specific immunity in vivo by PD-1 blockade
    Velu, Vijayakumar
    Titanji, Kehmia
    Zhu, Baogong
    Husain, Sajid
    Pladevega, Annette
    Lai, Lilin
    Vanderford, Thomas H.
    Chennareddi, Lakshmi
    Silvestri, Guido
    Freeman, Gordon J.
    Ahmed, Rafi
    Amara, Rama Rao
    NATURE, 2009, 458 (7235) : 206 - U5
  • [25] Enhancing SIV-specific immunity in vivo by PD-1 blockade
    Vijayakumar Velu
    Kehmia Titanji
    Baogong Zhu
    Sajid Husain
    Annette Pladevega
    Lilin Lai
    Thomas H. Vanderford
    Lakshmi Chennareddi
    Guido Silvestri
    Gordon J. Freeman
    Rafi Ahmed
    Rama Rao Amara
    Nature, 2009, 458 : 206 - 210
  • [26] The role of radiotherapy in tumor immunity and the potential of PET/CT in detecting the expression of PD-1/PD-L1
    Shen, Li-Fang
    Fu, Zi-Ming
    Zhou, Shui-Hong
    JAPANESE JOURNAL OF RADIOLOGY, 2023, 42 (4) : 347 - 353
  • [27] The role of radiotherapy in tumor immunity and the potential of PET/CT in detecting the expression of PD-1/PD-L1
    Li-Fang Shen
    Zi-Ming Fu
    Shui-Hong Zhou
    Japanese Journal of Radiology, 2024, 42 : 347 - 353
  • [28] Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer
    Fournel, Ludovic
    Wu, Zherui
    Stadler, Nicolas
    Damotte, Diane
    Lococo, Filippo
    Boulle, Geoffroy
    Segal-Bendirdjian, Evelyne
    Bobbio, Antonio
    Icard, Philippe
    Tredaniel, Jean
    Alifano, Marco
    Forgez, Patricia
    CANCER LETTERS, 2019, 464 : 5 - 14
  • [29] BET inhibitor JQ1 enhances anti-tumor immunity and synergizes with PD-1 blockade in CRC
    Wang, Huijin
    Liu, Guangyao
    Jin, Xinghan
    Song, Shenglei
    Chen, Songyao
    Zhou, Peiqing
    Li, Huan
    Liang, Jianming
    Li, Bo
    Zhang, Changhua
    He, Yulong
    JOURNAL OF CANCER, 2022, 13 (06): : 2126 - 2137
  • [30] Resistance Mechanism of PD-1/PD-L1 Blockade in the Cancer-Immunity Cycle
    Zhuang, Yuan
    Liu, Chang
    Liu, Jiaqing
    Li, Guang
    ONCOTARGETS AND THERAPY, 2020, 13 : 83 - 94
12345